[Hemophagocytic syndrome in a patient with rheumatoid arthritis]. 1998

J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
Department of Internal Medicine, Matsuyama Red Cross Hospital, Ehime.

A 62-year-old man with 16 year-history of rheumatoid arthritis (RA) was admitted due to progressive pancytopenia, general fatigue, and high fever. He was treated with 5 mg methotrexate weekly in RA. His bone marrow examination revealed a decreased nuclear cell count (2.1 x 10(4)/microliter), megakaryocyte count (16/microliter), and macrophages phagocytizing blood cells (13.2%), indicating the presence of hemophagocytic syndrome. No infections agent was detected in cultures derived from his blood or other sources. The serological tests for several viruses revealed no obvious viral etiology. The systemic lymphonodes were not swelling. Administration of 40 mg prednisolone daily improved his abnormal hematological findings. This is a case of RA accompanied by hemophagocytic syndrome, which is a rare complication of RA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D015616 Histiocytosis, Non-Langerhans-Cell Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES). Reticulohistiocytoma,Xanthoma Disseminatum,Disseminatum, Xanthoma,Histiocytosis, Non Langerhans Cell,Non-Langerhans-Cell Histiocytosis,Reticulohistiocytomas
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
October 2011, Modern rheumatology,
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
October 1994, Internal medicine (Tokyo, Japan),
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
January 2007, Internal medicine (Tokyo, Japan),
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
January 2012, Internal medicine (Tokyo, Japan),
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
October 2003, Ryumachi. [Rheumatism],
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
September 2018, European journal of rheumatology,
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
November 2004, La Revue de medecine interne,
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
April 2020, Internal medicine (Tokyo, Japan),
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
August 2017, BMJ case reports,
J Yamanouchi, and Y Yamauchi, and E Yokota, and I Matsumoto
March 1981, The American journal of medicine,
Copied contents to your clipboard!